Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Keila Bariotto-dos-Santos; Danilo Leandro Ribeiro; Rayanne Poletti Guimar&#227;es; Fernando  Eduardo Padovan-Neto

doi:10.3791/62924

Évaluation des dyskinésies induites par la L-DOPA dans le modèle unilatéral de la maladie de Park...

JoVE Journal
Biology

A subscription to JoVE is required to view this content. Sign in or start your free trial.

JoVE Journal Biology

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson’s Disease

Évaluation des dyskinésies induites par la L-DOPA dans le modèle unilatéral de la maladie de Parkinson chez le rat à 6-OHDA

Full Text

3,489 Views

06:45 min

October 4, 2021

DOI: 10.3791/62924-v

Keila Bariotto-dos-Santos*¹, Danilo Leandro Ribeiro*¹, Rayanne Poletti Guimarães¹, Fernando Eduardo Padovan-Neto¹

¹Department of Psychology, Faculty of Philosophy, Sciences and Letters of Ribeirão Preto,University of São Paulo

Please note that some of the translations on this page are AI generated. Click here for the English version.

Overview

This study utilizes the 6-hydroxydopamine (6-OHDA) rat model of Parkinson's disease to investigate L-DOPA-induced dyskinesias, aiming to identify therapeutic interventions. The chronic treatment with L-DOPA allows for the assessment of abnormal involuntary movements, providing insights into potential antidyskinetic strategies.

Key Study Components

Research Area

Neuroscience
Pharmacology
Pediatric Medicine

Background

L-DOPA treatment is commonly associated with dyskinesias in Parkinson's disease patients.
Rodent models enable the study of therapeutic effects on dyskinesias.
The 6-OHDA lesion mimics pathophysiological changes seen in human Parkinson's disease.

Methods Used

Stereotaxic administration of 6-OHDA in Sprague-Dawley male rats.
Chronic L-DOPA treatment with benserazide.
Video analysis of abnormal involuntary movements post-treatment.

Main Results

L-DOPA treatment resulted in peak-dose dyskinesias between 30 to 90 minutes.
Patterns of axial, limb, and orolingual movements were systematically scored.
The model effectively mimicked clinical observations of dyskinesias.

Conclusions

This study demonstrates a reliable method to assess L-DOPA-induced dyskinesias.
It underscores the significance of rodent models in developing antidyskinetic therapies.

Frequently Asked Questions

What is L-DOPA-induced dyskinesia?

L-DOPA-induced dyskinesia refers to abnormal involuntary movements that occur as a side effect of long-term treatment with L-DOPA in Parkinson's disease patients.

How is the 6-OHDA model relevant to Parkinson's research?

The 6-OHDA model replicates dopamine depletion seen in Parkinson's disease, allowing for the study of treatments aimed at managing symptoms.

What are the key observations in this study?

Key observations include the timing of dyskinetic movements relative to L-DOPA administration and the assessment of these movements in a controlled environment.

Why is video analysis used in this research?

Video analysis allows for accurate, qualitative scoring of abnormal movements from multiple angles, enhancing the reliability of the observations.

How does this study contribute to antidyskinetic therapy research?

The findings provide insights into the mechanisms and timing of dyskinesias, informing the development of targeted therapeutic interventions.

What implications does this research have for clinical practice?

Understanding dyskinesia onset and severity can guide more effective treatment strategies for Parkinson's patients, improving their quality of life.

Are the animal models used in this study relevant for humans?

Yes, rodent models like the 6-OHDA model have significant predictive validity for human conditions, making them valuable for preclinical research.

Les modèles de dyskinésies induites par la L-DOPA chez les rongeurs sont des outils précieux pour identifier les interventions thérapeutiques visant à atténuer le développement ou à atténuer les manifestations qui émergent en raison de l’administration répétée de L-DOPA. Ce protocole démontre comment induire et analyser des mouvements de type dyskinétique dans le modèle unilatéral de la maladie de Parkinson chez le rat 6-OHDA.

L’évaluation des dyskinésies induites par la L-DOPA dans le modèle de la maladie de Parkinson chez le rat 6-hydroxydopamine est un outil préclinique important pour identifier des interventions antidyskinétiques efficaces. Ce modèle est relativement simple, présente un faible coût et présente des similitudes avec ce qui se passe en clinique. La procédure sera démontrée par Danilo Leandro Ribeiro, doctorant au laboratoire.

Commencez l’expérience avec des rats mâles Sprague-Dawley, pesant de 200 à 250 grammes. Hébergez deux à trois animaux par cage dans les conditions de laboratoire standard avec de la nourriture et de l’eau disponibles ad libitum. Avant la chirurgie, administrer l’inhibiteur du transporteur de la noradrénaline, l’imipramine, au rat par voie intrapéritonéale.

View the full transcript and gain access to thousands of scientific videos